This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n4http://linked.opendata.cz/resource/drugbank/drug/DB03888/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB03888/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03888/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03888/identifier/pdb/

Statements

Subject Item
n2:DB03888
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB03888 n12:DB03888
dcterms:title
Allyl-{6-[3-(4-Bromo-Phenyl)-1-Methyl-1h-Indazol-6-Yl]Oxy}Hexyl)-N-Methylamine
adms:identifier
n4:445989 n5:46508151 n10:DB03888 n11:R03
n6:IUPAC-Name
n7:271B4C68-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B4C6E-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B4C6D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B4C6A-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B4C6B-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B4C6C-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4C66-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4C67-363D-11E5-9242-09173F13E4C5 n7:271B4C64-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4C65-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4C74-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4C75-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B4C6F-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4C70-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4C72-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4C71-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4C73-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B4C79-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B4C7B-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B4C7C-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4C78-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4C77-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B4C7A-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4C69-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4C76-363D-11E5-9242-09173F13E4C5